Covid-19 vaccines, according to a report by Oxfam on Wednesday.The non-governmental organization analyzed deals struck by pharmaceuticals and vaccine producers for the five leading vaccine candidates currently in late-stage trials, based on data collected by the analytics company Airfinity."Access to a life-saving vaccine shouldn't depend on where you live or how much money you have," said Robert Silverman of Oxfam America."The development and approval of a safe and effective vaccine is crucial, but equally important is making sure the vaccines are available and affordable to everyone.
Covid-19 anywhere is Covid-19 everywhere."The five vaccines analyzed were from AstraZeneca, Gamaleya/Sputnik, Moderna, Pfizer and Sinovac.Oxfam calculated.